Dr. Sarah Iribarren’s program of research focuses on developing innovative patient-centered approaches to bridge gaps between patients and health care professionals to improve clinical outcomes. In particular, her efforts have focused on TB and HIV prevention and treatment management within low- and middle-income settings and amongst disadvantaged populations. Dr. Iribarren is currently the Principal Investigator of an NIH K23 (K23NR017210) to develop and pilot test the TB-Treatment Support Tools mobile intervention and MPI on an NIH R01 (R01AI147129) to further refine the intervention and evaluate its impact by a randomized controlled trial. She is also a co-investigator on a PAHO funded study to understand the utilization of health services and the needs for sexual and reproductive health of Venezuelan migrant women in Quito, Ecuador. She is also providing support to a HRSA grant to enhance the BSN curriculum and create modules related to health informatics and patient and provider-centered technologies to assist in managing chronic & substance-use conditions. During doctoral studies, Dr. Iribarren was a Fogarty International Clinical Research Scholar in Argentina, where she worked with research teams and regional and national leaders to understand the challenges of TB management, particularly within vulnerable populations.